SCHEMBL2013350

SCHEMBL2013350

Fc1cccc(-c2cc[c]cc2Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.38
ESR2 Q92731 1/20 0.38
IDO1 P14902 2/20 0.37
NT5E P21589 2/20 0.36
KDM4E B2RXH2 1/20 0.36
HPGD P15428 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
CDC7 O00311 1/20 0.35
ROCK2 O75116 1/20 0.35
MAP4K4 O95819 1/20 0.35
PIM1 P11309 1/20 0.35
PRKACA P17612 1/20 0.35
CDK2 P24941 1/20 0.35
GSK3B P49841 1/20 0.35
HIPK2 Q9H2X6 1/20 0.35
CLK4 Q9HAZ1 1/20 0.35
IRAK4 Q9NWZ3 1/20 0.35
MAPK10 P53779 1/20 0.34
NOTUM Q6P988 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2015119 0.84 AHR (0.31)
SCHEMBL4209132 0.82 TAAR1 (0.40) TAAR1ESR2IDO1NT5EKDM4E
SCHEMBL9648712 0.82 TDO2 (0.40) TAAR1ESR2IDO1NOTUMMEN1
SCHEMBL9769412 0.79 HSD17B1 (0.44) ESR2ALDH1A1HSD17B1HSD17B2
SCHEMBL2012945 0.79 ACHE (0.39) TAAR1ESR2KDM4EHPGDNPSR1
SCHEMBL16720132 0.79 ESR2 (0.46) TAAR1ESR2KDM4EHPGDNPSR1
SCHEMBL695054 0.79 RORB (0.48) IDO1KDM4EHPGDNPSR1CDK2
SCHEMBL27707563 0.79 TAAR1 (0.40) TAAR1ESR2IDO1NT5EKDM4E
SCHEMBL2012244 0.78 PTGS2 (0.39) KDM4EALDH1A1
SCHEMBL2093448 0.77 CYP2A6 (0.54) ESR2KDM4EHPGDNPSR1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103664993-B Compound of one class treatment ischemic brain damage and uses thereof HAN BING (CN) 2016-05-25 CN claimed
CN-111212643-A Combination therapy 梅制药公司 2020-05-29 CN disclosed
WO-2013182433-A1 A PROCESS USING GRIGNARD REAGENTS BASF SE (DE) 2013-12-12 WO disclosed
EP-2547687-A1 A PROCESS USING GRIGNARD REAGENTS BASF SE (DE) 2013-01-23 EP disclosed
EP-2513067-A1 METHOD FOR PRODUCING TRIAZOLINTHIONE DERIVATIVES AND INTERMEDIATES THEREOF BASF SE (DE) 2012-10-24 EP disclosed
WO-2011113820-A1 A PROCESS USING GRIGNARD REAGENTS BASF SE (DE) 2011-09-22 WO disclosed
WO-2011073145-A1 METHOD FOR PRODUCING TRIAZOLINTHIONE DERIVATIVES AND INTERMEDIATES THEREOF BASF SE (DE) 2011-06-23 WO disclosed
WO-2004030671-A2 USE OF 4-AMINO-QUINAZOLINES AS ANTI CANCER AGENTS MERCK PATENT GMBH (DE) 2004-04-15 WO disclosed